OfferingRegistry
Offerings / Regulation CF / Clarify AI, Inc.

Clarify AI, Inc.

Regulation Crowdfunding offering on Andes Capital · Form C filed September 25, 2026 · Los Angeles, California

Common stockPre-revenueCorporation, DelawareHealthcareHealthtech (B2B medical billing error detection software)

ClarifyAI, Inc. is developing a B2B healthtech platform intended to help self-insured employers detect, dispute and resolve medical billing errors. The company is pre-seed and pre-revenue, with no current employees and $0 revenue reported.

Registry notesJodd Readick and Jonathan Destler together hold about 82.9% of voting power, and the company reports $9,194 of non-interest-bearing shareholder advances due on demand. The document is a draft that marks several figures and share counts as unresolved, so reported amounts may change.

Profile details below were extracted automatically from the issuer's filing documents. Figures in the financial table come directly from the SEC's structured Form C data.

Offering terms

Security
Common Stock
Maximum
$1,200,000.00
Price
$0.30 per unit
Pricing method
Chosen by management based on its estimation of value
Deadline
December 31, 2026
Oversubscriptions
Accepted
Intermediary
ANDES CAPITAL GROUP, LLC
Broker-dealer, SEC file 008-67202
Intermediary fee
$3,000 expenses plus 3% of each raise on closing
Intermediary equity
None

Financials as filed

ItemMost recent FYPrior FY
Revenue$0$0
Cost of goods sold$0$0
Net income (loss)-$13,351-$2,419
Total assets$3,737$4,180
Cash and equivalents$3,737$4,180
Accounts receivable$0$0
Short-term debt$9,194$9,194
Long-term debt$0$0
Taxes paid$0$0

Two fiscal years as reported on the Form C cover sheet. 0 employees. Offered in 52 states.

Use of proceeds

At the $1,200,000 maximum, $240,000 each goes to technology development and presales and marketing, $180,000 each to data source licensing and MVP definition, and $120,000 each to digital marketing, office infrastructure, and legal and recruiting costs.

Valuation

Pre-money valuation of about $6,389,550 (Appendix A), based on $0.30 per share of common stock and management's judgment; the filing notes that investor materials contain valuation language still to be reconciled. Valuation cap, discount and interest rate: Not stated.

Prior raises

The draft table lists share issuances from December 2024 through May 2026, including 19,627,500 shares at $0.0001 (listed as $1,962.75), 550,000 shares at $0.01 ($5,500), 600,000 shares at $0.15 (listed as $75,000) and about 33,333 shares at $0.30 ($10,000) in May 2026; the filing marks several entries as unresolved and its exemption entries as placeholders.

Financial statements

Reviewed, not audited, under an independent accountant's review report dated July 20, 2026 from an unnamed CPA firm in Cooper City, Florida, covering the years ended December 31, 2025 and 2024.